BMO Capital analyst Michael Zaremski raised the firm’s price target on Skyward Specialty Insurance to $31 from $29 and keeps a Market Perform rating on the shares. The firm remains confident in the company’s near-term RoE profile improving given that it continues to opportunistically grow into an attractive excess & surplus “E&S” cycle, though its target price upside is tempered by the stock’s ultimate valuation having had a big run year-to-date, the analyst tells investors in a research note.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on SKWD:
- Skyward Specialty Adds Mike Morrissey to Its Board of Directors
- Skyward Specialty Insurance initiated with bullish view at Jefferies, here’s why
- Skyward Specialty Insurance price target raised to $36 from $34 at Piper Sandler
- Skyward Specialty Insurance price target raised to $36 from $30 at Raymond James
- Skyward Specialty Insurance 5M share Secondary priced at $30.50